Topics

Aimmune’s Palforzia gets FDA approval for treatment of peanut allergy

07:21 EST 3 Feb 2020 | Pharmaceutical Business Review

Palforzia, which was formerly known as AR101, has been indicated in the US for the mitigation of anaphylaxis and other allergic reactions following accidental exposure to peanut. The

The post Aimmune’s Palforzia gets FDA approval for treatment of peanut allergy appeared first on Pharmaceutical Business review.

Original Article: Aimmune’s Palforzia gets FDA approval for treatment of peanut allergy

NEXT ARTICLE

More From BioPortfolio on "Aimmune’s Palforzia gets FDA approval for treatment of peanut allergy"

Quick Search

Relevant Topic

Allergies
The term allergy is used to describe a response, within the body, to a substance, which is not necessarily harmful in itself, but results in an immune response and a reaction that causes symptoms and disease in a predisposed person, which in turn can cau...